Christopher Ziebenhaus

Christopher Ziebenhaus is an experienced scientist with a focus on medicinal chemistry and organic chemistry. Currently serving as Scientist I at Maze Therapeutics since March 2021, Christopher previously held the position of Senior Research Associate II. Prior experience includes a role as Senior Research Associate in Medicinal Chemistry at Gilead Sciences from November 2015 to February 2021, and as a Research Assistant at Queen's University from September 2013 to October 2015, collaborating on MSc research with Professor Crudden. Christopher also completed undergraduate research under Professors Victor Snieckus at Queen’s University, culminating in an Honour's Thesis focused on total syntheses. Christopher holds a Master's Degree in Organic Chemistry and a Bachelor's Degree in Chemistry, both from Queen's University.